Table: Shin Nippon Biomedical -Q1 group results

Shin Nippon Biomedical Laboratories

07/08/2020 04:00

Aug 7 (Reuters)- 
             Shin Nippon Biomedical Laboratories Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2020        Jun 30, 2019     Mar 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             3.17                2.73             14.81    
                 (+16.2 pct)         (-26.5 pct)      (+1.7 pct)  
  Operating        447 mln             273 mln            1.80    
                 (+63.7 pct)                          (-19.2 pct) 
  Recurring        732 mln             49 mln             2.20    
                                     (-91.2 pct)      (-29.5 pct) 
  Net              643 mln           loss 41 mln          1.80    
                                                      (-29.4 pct) 
  EPS             15.45 yen         loss 0.99 yen      43.23 yen  
  Ann Div                             5.00 yen         5.00 yen   
  -Q2 div                                NIL              NIL     
  -Q4 div                             5.00 yen         5.00 yen   
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T